arrow_back Trending Legislation
Share share

Pharmacies to Deliver Controlled Substances Directly to Practitioners

New rules allow pharmacies to deliver certain controlled substances directly to medical practitioners instead of patients. This aims to streamline the administration of these medications by healthcare professionals, especially those requiring medical supervision. The change could improve the treatment process for individuals needing such substances.
Key points
Pharmacies can now send selected controlled substances (Schedules III, IV, or V) directly to medical offices.
These medications must be intended for administration by or under the supervision of a practitioner.
The change aims to simplify access to medications for medical facilities that administer them.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.
Print number: HR 4490
Sponsor: Rep. Guthrie, Brett [R-KY-2]
Process start date: 2023-07-06
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Pharmacies to Deliver Controlled Substances Directly to Practitioners

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 4490.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-07-06.

What are the main provisions?

Key points include:

  • Pharmacies can now send selected controlled substances (Schedules III, IV, or V) directly to medical offices.
  • These medications must be intended for administration by or under the supervision of a practitioner.
  • The change aims to simplify access to medications for medical facilities that administer them.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Guthrie, Brett [R-KY-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 4490

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Courts and Law